DEveloping BBB-ASL as non-Invasive Early biomarker of Alzheimer's Disease (DEBBIE-AD): Study design
Arterial spin labeling (ASL) MRI, a non-invasive technique for imaging perfusion, now allows studying BBB permeability. The DEveloping BBB-ASL as a non-Invasive Early biomarker of Alzheimer's Disease (DEBBIE-AD) multi-cohort study integrates this modified BBB-ASL technique in several healthy an...
Gespeichert in:
| Veröffentlicht in: | Cerebral circulation - cognition and behavior Jg. 6; S. 100308 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
Elsevier B.V
2024
Elsevier |
| ISSN: | 2666-2450, 2666-2450 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | Arterial spin labeling (ASL) MRI, a non-invasive technique for imaging perfusion, now allows studying BBB permeability. The DEveloping BBB-ASL as a non-Invasive Early biomarker of Alzheimer's Disease (DEBBIE-AD) multi-cohort study integrates this modified BBB-ASL technique in several healthy and diseased populations (Table 1) to study methodological and clinical research questions (Table 2) on the ability of BBB-ASL as an early AD biomarker.
DEBBIE-AD will enroll various cohorts with subjective cognitive decline, mild cognitive impairment, and AD dementia, as well as age-matched healthy controls, at seven sites (Table 1). Our newly developed BBB-ASL sequence — implemented with the vendor-independent MRI framework gammaSTAR — will be added to multiple MRI protocols. The BBB-ASL sequence combines time-encoded multi-post labeling delay pseudo-continuous ASL with a multi-echo 3D GRASE readout, allowing estimating CBF, ATT, and the BBB time of exchange (Tex). Data analyses will be conducted using ExploreASL. Beyond MRI standard sequences, including T1w, T2w, FLAIR, DWI, the DEBBIE clinical outcomes include amyloid-PET and blood and CSF fluid biomarkers (Table 1).
Preliminary testing of the BBB-ASL has been conducted on 3T systems (different Siemens Heathineers scanners) in different cohorts at multiple sites. Data processing with ExploreASL includes FSL-FABBER4 for quantification, allowing harmonized image processing. An example of the mean and standard deviation Tex maps of two DEBBIE cohorts is shown in Figure 1 to illustrate the similarities of the Tex patterns from two cohorts of similar-aged healthy adults from different sites.
The DEBBIE-AD study aims to provide evidence on the ability of BBB-ASL to measure BBB permeability and demonstrate its utility in AD-related pathologies. The presented sequence may provide novel and unique insights into the staging of BBB permeability changes in groups at greater risk of developing AD, which may, in turn, provide new targets for treatment. |
|---|---|
| AbstractList | Arterial spin labeling (ASL) MRI, a non-invasive technique for imaging perfusion, now allows studying BBB permeability. The DEveloping BBB-ASL as a non-Invasive Early biomarker of Alzheimer's Disease (DEBBIE-AD) multi-cohort study integrates this modified BBB-ASL technique in several healthy and diseased populations (Table 1) to study methodological and clinical research questions (Table 2) on the ability of BBB-ASL as an early AD biomarker.
DEBBIE-AD will enroll various cohorts with subjective cognitive decline, mild cognitive impairment, and AD dementia, as well as age-matched healthy controls, at seven sites (Table 1). Our newly developed BBB-ASL sequence — implemented with the vendor-independent MRI framework gammaSTAR — will be added to multiple MRI protocols. The BBB-ASL sequence combines time-encoded multi-post labeling delay pseudo-continuous ASL with a multi-echo 3D GRASE readout, allowing estimating CBF, ATT, and the BBB time of exchange (Tex). Data analyses will be conducted using ExploreASL. Beyond MRI standard sequences, including T1w, T2w, FLAIR, DWI, the DEBBIE clinical outcomes include amyloid-PET and blood and CSF fluid biomarkers (Table 1).
Preliminary testing of the BBB-ASL has been conducted on 3T systems (different Siemens Heathineers scanners) in different cohorts at multiple sites. Data processing with ExploreASL includes FSL-FABBER4 for quantification, allowing harmonized image processing. An example of the mean and standard deviation Tex maps of two DEBBIE cohorts is shown in Figure 1 to illustrate the similarities of the Tex patterns from two cohorts of similar-aged healthy adults from different sites.
The DEBBIE-AD study aims to provide evidence on the ability of BBB-ASL to measure BBB permeability and demonstrate its utility in AD-related pathologies. The presented sequence may provide novel and unique insights into the staging of BBB permeability changes in groups at greater risk of developing AD, which may, in turn, provide new targets for treatment. Introduction: Arterial spin labeling (ASL) MRI, a non-invasive technique for imaging perfusion, now allows studying BBB permeability. The DEveloping BBB-ASL as a non-Invasive Early biomarker of Alzheimer's Disease (DEBBIE-AD) multi-cohort study integrates this modified BBB-ASL technique in several healthy and diseased populations (Table 1) to study methodological and clinical research questions (Table 2) on the ability of BBB-ASL as an early AD biomarker. Methods: DEBBIE-AD will enroll various cohorts with subjective cognitive decline, mild cognitive impairment, and AD dementia, as well as age-matched healthy controls, at seven sites (Table 1). Our newly developed BBB-ASL sequence — implemented with the vendor-independent MRI framework gammaSTAR — will be added to multiple MRI protocols. The BBB-ASL sequence combines time-encoded multi-post labeling delay pseudo-continuous ASL with a multi-echo 3D GRASE readout, allowing estimating CBF, ATT, and the BBB time of exchange (Tex). Data analyses will be conducted using ExploreASL. Beyond MRI standard sequences, including T1w, T2w, FLAIR, DWI, the DEBBIE clinical outcomes include amyloid-PET and blood and CSF fluid biomarkers (Table 1). Expected Results: Preliminary testing of the BBB-ASL has been conducted on 3T systems (different Siemens Heathineers scanners) in different cohorts at multiple sites. Data processing with ExploreASL includes FSL-FABBER4 for quantification, allowing harmonized image processing. An example of the mean and standard deviation Tex maps of two DEBBIE cohorts is shown in Figure 1 to illustrate the similarities of the Tex patterns from two cohorts of similar-aged healthy adults from different sites. Discussion: The DEBBIE-AD study aims to provide evidence on the ability of BBB-ASL to measure BBB permeability and demonstrate its utility in AD-related pathologies. The presented sequence may provide novel and unique insights into the staging of BBB permeability changes in groups at greater risk of developing AD, which may, in turn, provide new targets for treatment. |
| ArticleNumber | 100308 |
| Author | Petr, Jan Mutsaerts, Henk J.M.M. Morgan, Catherine Pålhaugen, Lene Linn, Jennifer de Leeuw, Diederick Buck, Mareike Tijms, Betty Moyaert, Paulien Rikken, Roos Fladby, Tormod Wiersinga, Julia Ozturk-Isik, Esin Clement, Patricia Padrela, Beatriz Barkhof, Frederik Hilal, Saima Walhovd, Kristine Fjell, Anders Brandt, Moritz Tee, Mervin Zhu, Yufei David Konstandin, Simon Grydeland, Håkon Muller, Majon Eickel, Klaus Sneve, Markus Selnes, Per Cawston, Erin Huber, Jörn Mahroo, Amnah Tippett, Lynette Achten, Eric Nordhøy, Wibeke Anazodo, Udunna van de Giessen, Elsmarieke Geier, Oliver Günther, Matthias Beun, Soetkin Thomas, David Hoinkiss, Daniel Kuijer, Joost |
| Author_xml | – sequence: 1 givenname: Beatriz surname: Padrela fullname: Padrela, Beatriz organization: Department of Radiology and Nuclear Medicine, Amsterdam Neuroscience, Amsterdam University Medical Center, Location VUmc, Amsterdam, the Netherlands – sequence: 2 givenname: Amnah surname: Mahroo fullname: Mahroo, Amnah organization: Fraunhofer-Institute for Digital Medicine MEVIS, Bremen, Germany – sequence: 3 givenname: Mervin surname: Tee fullname: Tee, Mervin organization: Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore – sequence: 4 givenname: Markus surname: Sneve fullname: Sneve, Markus organization: Department of Psychology, Center for Lifespan Changes in Brain and Cognition, University of Oslo, Oslo, Norway – sequence: 5 givenname: Paulien surname: Moyaert fullname: Moyaert, Paulien organization: Lawson Health Research Institute, London, Ontario, Canada – sequence: 6 givenname: Oliver surname: Geier fullname: Geier, Oliver organization: Department of Physics and Computational Radiology, Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway – sequence: 7 givenname: Joost surname: Kuijer fullname: Kuijer, Joost organization: Department of Radiology and Nuclear Medicine, Amsterdam Neuroscience, Amsterdam University Medical Center, Location VUmc, Amsterdam, the Netherlands – sequence: 8 givenname: Soetkin surname: Beun fullname: Beun, Soetkin organization: Department of Diagnostic Sciences, Ghent University, Ghent, Belgium – sequence: 9 givenname: Wibeke surname: Nordhøy fullname: Nordhøy, Wibeke organization: Department of Physics and Computational Radiology, Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway – sequence: 10 givenname: Yufei David surname: Zhu fullname: Zhu, Yufei David organization: Biomedical Engineering, University of California, Davis, Davis, CA – sequence: 11 givenname: Mareike surname: Buck fullname: Buck, Mareike organization: University of Bremen, Bremen, Germany – sequence: 12 givenname: Daniel surname: Hoinkiss fullname: Hoinkiss, Daniel organization: Fraunhofer-Institute for Digital Medicine MEVIS, Bremen, Germany – sequence: 13 givenname: Simon surname: Konstandin fullname: Konstandin, Simon organization: Fraunhofer-Institute for Digital Medicine MEVIS, Bremen, Germany – sequence: 14 givenname: Jörn surname: Huber fullname: Huber, Jörn organization: Fraunhofer-Institute for Digital Medicine MEVIS, Bremen, Germany – sequence: 15 givenname: Julia surname: Wiersinga fullname: Wiersinga, Julia organization: Department of Internal Medicine, Geriatrics Section, Amsterdam Cardiovascular Sciences Institute, Amsterdam University Medical Centers, Location VUmc, Amsterdam, the Netherlands – sequence: 16 givenname: Roos surname: Rikken fullname: Rikken, Roos organization: Department of Radiology and Nuclear Medicine, Amsterdam Neuroscience, Amsterdam University Medical Center, Location VUmc, Amsterdam, the Netherlands – sequence: 17 givenname: Diederick surname: de Leeuw fullname: de Leeuw, Diederick organization: Alzheimer Center Amsterdam, Neurology, Amsterdam Neuroscience, Amsterdam University Medical Centers, Location VUmc, Amsterdam, The Netherlands – sequence: 18 givenname: Håkon surname: Grydeland fullname: Grydeland, Håkon organization: Department of Psychology, Center for Lifespan Changes in Brain and Cognition, University of Oslo, Oslo, Norway – sequence: 19 givenname: Lynette surname: Tippett fullname: Tippett, Lynette organization: University of Auckland, School of Psychology and Centre for Brain Research, Auckland, New Zealand – sequence: 20 givenname: Erin surname: Cawston fullname: Cawston, Erin organization: University of Auckland, Department of Pharmacology and Centre for Brain Research, Auckland, New Zealand – sequence: 21 givenname: Esin surname: Ozturk-Isik fullname: Ozturk-Isik, Esin organization: Institute of Biomedical Engineering, Bogazici University, Istanbul, Turkey – sequence: 22 givenname: Jennifer surname: Linn fullname: Linn, Jennifer organization: Department of Neurology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany – sequence: 23 givenname: Moritz surname: Brandt fullname: Brandt, Moritz organization: Department of Neurology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany – sequence: 24 givenname: Betty surname: Tijms fullname: Tijms, Betty organization: Alzheimer Center Amsterdam, Neurology, Amsterdam Neuroscience, Amsterdam University Medical Centers, Location VUmc, Amsterdam, The Netherlands – sequence: 25 givenname: Elsmarieke surname: van de Giessen fullname: van de Giessen, Elsmarieke organization: Department of Radiology and Nuclear Medicine, Amsterdam Neuroscience, Amsterdam University Medical Center, Location VUmc, Amsterdam, the Netherlands – sequence: 26 givenname: Majon surname: Muller fullname: Muller, Majon organization: Department of Internal Medicine, Geriatrics Section, Amsterdam Cardiovascular Sciences Institute, Amsterdam University Medical Centers, Location VUmc, Amsterdam, the Netherlands – sequence: 27 givenname: Anders surname: Fjell fullname: Fjell, Anders organization: Department of Psychology, Center for Lifespan Changes in Brain and Cognition, University of Oslo, Oslo, Norway – sequence: 28 givenname: Kristine surname: Walhovd fullname: Walhovd, Kristine organization: Department of Psychology, Center for Lifespan Changes in Brain and Cognition, University of Oslo, Oslo, Norway – sequence: 29 givenname: Lene surname: Pålhaugen fullname: Pålhaugen, Lene organization: Department of Neurology, Akershus University Hospital, Lørenskog, Norway – sequence: 30 givenname: Per surname: Selnes fullname: Selnes, Per organization: Department of Neurology, Akershus University Hospital, Lørenskog, Norway – sequence: 31 givenname: Patricia surname: Clement fullname: Clement, Patricia organization: Department of Diagnostic Sciences, Ghent University, Ghent, Belgium – sequence: 32 givenname: Eric surname: Achten fullname: Achten, Eric organization: Department of Diagnostic Sciences, Ghent University, Ghent, Belgium – sequence: 33 givenname: Udunna surname: Anazodo fullname: Anazodo, Udunna organization: Lawson Health Research Institute, London, Ontario, Canada – sequence: 34 givenname: Frederik surname: Barkhof fullname: Barkhof, Frederik organization: Department of Radiology and Nuclear Medicine, Amsterdam Neuroscience, Amsterdam University Medical Center, Location VUmc, Amsterdam, the Netherlands – sequence: 35 givenname: Saima surname: Hilal fullname: Hilal, Saima organization: Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore – sequence: 36 givenname: Tormod surname: Fladby fullname: Fladby, Tormod organization: Department of Neurology, Akershus University Hospital, Lørenskog, Norway – sequence: 37 givenname: Klaus surname: Eickel fullname: Eickel, Klaus organization: Fraunhofer-Institute for Digital Medicine MEVIS, Bremen, Germany – sequence: 38 givenname: Catherine surname: Morgan fullname: Morgan, Catherine organization: University of Auckland, School of Psychology and Centre for Brain Research, Auckland, New Zealand – sequence: 39 givenname: David surname: Thomas fullname: Thomas, David organization: Department of Brain Repair and Rehabilitation, UCL Queen Square Institute of Neurology, University College London, UK – sequence: 40 givenname: Jan surname: Petr fullname: Petr, Jan organization: Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany – sequence: 41 givenname: Matthias surname: Günther fullname: Günther, Matthias organization: Fraunhofer-Institute for Digital Medicine MEVIS, Bremen, Germany – sequence: 42 givenname: Henk J.M.M. surname: Mutsaerts fullname: Mutsaerts, Henk J.M.M. organization: Department of Radiology and Nuclear Medicine, Amsterdam Neuroscience, Amsterdam University Medical Center, Location VUmc, Amsterdam, the Netherlands |
| BookMark | eNp9kEFvEzEQhS1UJErpH-DkW8thw9jr9Tqol2yzQKRIHApny54dB6fb3cpOI6W_ng1BVU-cZvSk982b956dDeNAjH0UMBMg9OftDBH9TIJUkwAlmDfsXGqtC6kqOHu1v2OXOW8BQFZCmFKcM1y2e-rHxzhseNM0xeJuzV3m04ViNexdjnvirUv9gfs4Prh0T4mPgS_6598UHyhdZb6MmVwmfr1sm2bVFovlpy_8bvfUHXhHOW6GD-xtcH2my3_zgv362v68_V6sf3xb3S7WBUrQplCOyFcdelUKD8aZem6qTjqoahOEAE11p2VXhgq9lEZICIgGSsR5mGtvygu2OnG70W3tY4pT3oMdXbR_hTFtrEu7iD3ZMCeFoVRGBa8qXTs3MYLxAmQtScHEkicWpjHnROGFJ8AeW7dbe2zdHlu3p9Yn083JRNOX-0jJZow0IHUxEe6mGPF_9j9QJIl_ |
| ContentType | Journal Article |
| Copyright | 2024 |
| Copyright_xml | – notice: 2024 |
| DBID | 6I. AAFTH AAYXX CITATION DOA |
| DOI | 10.1016/j.cccb.2024.100308 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: DOA name: DAOJ: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website |
| DeliveryMethod | fulltext_linktorsrc |
| EISSN | 2666-2450 |
| ExternalDocumentID | oai_doaj_org_article_f9e4cf3484fb4567aa9f9f8b10272e40 10_1016_j_cccb_2024_100308 S2666245024001090 |
| GroupedDBID | .1- .FO 0R~ 0SF 1P~ 6I. AAEDW AAFTH AALRI AAXUO ADVLN AFRHN AITUG AJUYK ALMA_UNASSIGNED_HOLDINGS AMRAJ EBS FDB GROUPED_DOAJ RPM Z5R AAYWO AAYXX AFJKZ APXCP CITATION |
| ID | FETCH-LOGICAL-c2068-4aeeb5dcb431b08a87985d2a0578f1106e7d62d3f5cb228120fcc803cc9f96b83 |
| IEDL.DBID | DOA |
| ISSN | 2666-2450 |
| IngestDate | Fri Oct 03 12:43:50 EDT 2025 Sat Nov 29 02:23:43 EST 2025 Sat Sep 07 15:50:49 EDT 2024 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Language | English |
| License | http://creativecommons.org/licenses/by-nc-nd/4.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c2068-4aeeb5dcb431b08a87985d2a0578f1106e7d62d3f5cb228120fcc803cc9f96b83 |
| OpenAccessLink | https://doaj.org/article/f9e4cf3484fb4567aa9f9f8b10272e40 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_f9e4cf3484fb4567aa9f9f8b10272e40 crossref_primary_10_1016_j_cccb_2024_100308 elsevier_sciencedirect_doi_10_1016_j_cccb_2024_100308 |
| PublicationCentury | 2000 |
| PublicationDate | 2024 2024-00-00 2024-01-01 |
| PublicationDateYYYYMMDD | 2024-01-01 |
| PublicationDate_xml | – year: 2024 text: 2024 |
| PublicationDecade | 2020 |
| PublicationTitle | Cerebral circulation - cognition and behavior |
| PublicationYear | 2024 |
| Publisher | Elsevier B.V Elsevier |
| Publisher_xml | – name: Elsevier B.V – name: Elsevier |
| SSID | ssj0002511831 |
| Score | 2.242238 |
| Snippet | Arterial spin labeling (ASL) MRI, a non-invasive technique for imaging perfusion, now allows studying BBB permeability. The DEveloping BBB-ASL as a... Introduction: Arterial spin labeling (ASL) MRI, a non-invasive technique for imaging perfusion, now allows studying BBB permeability. The DEveloping BBB-ASL as... |
| SourceID | doaj crossref elsevier |
| SourceType | Open Website Index Database Publisher |
| StartPage | 100308 |
| Title | DEveloping BBB-ASL as non-Invasive Early biomarker of Alzheimer's Disease (DEBBIE-AD): Study design |
| URI | https://dx.doi.org/10.1016/j.cccb.2024.100308 https://doaj.org/article/f9e4cf3484fb4567aa9f9f8b10272e40 |
| Volume | 6 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DAOJ: Directory of Open Access Journals customDbUrl: eissn: 2666-2450 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0002511831 issn: 2666-2450 databaseCode: DOA dateStart: 20200101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1NS8QwEA2yePAiiorrFzkIKlLsdxNvre2iIIugwt5KPnFFV-muC_rrzSSt9KQXr6Uk4U3pe9O-mUHoWARM6ADKfpMkg0833KNMJZ6OmJZQiklTbodNZOMxmUzoXW_UF3jCXHtgB9yFpioWOopJrLkh-4wxqqkm3KyfhSq22bpRPb1kCt7BVjhHQVsl4wxdQghuEsIwBmdABPMke0xkG_b3CKlHMqMNtN6qQ5y7U22iFTXbQqKsusImXBSFl9_fYjbHJm_3bmZLBv5zbPsUY6ilB7tNg980zl--ntT0VTUnc1y63zD4tKxM3lt5eXl2icFC-ImltXBso8dR9XB17bWzETwR-inxYqYUT6TgRgBwnzCSUZLIkBn5RbSh9FRlMg1lpBPBw9CwuK-FIH4khIEv5STaQQNzTrWLcOT7PAmJDFKaxtJkYETFMlBGekBRq2ZDdN7hVL-7Fhh15w17rgHVGlCtHapDVACUP3dC-2p7wQS1boNa_xXUIUq6QNStEnAMb5aa_rL53n9svo_WYEn3neUADRbNhzpEq2K5mM6bI_ucfQMIxNPy |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=DEveloping+BBB-ASL+as+non-Invasive+Early+biomarker+of+Alzheimer%27s+Disease+%28DEBBIE-AD%29%3A+Study+design&rft.jtitle=Cerebral+circulation+-+cognition+and+behavior&rft.au=Padrela%2C+Beatriz&rft.au=Mahroo%2C+Amnah&rft.au=Tee%2C+Mervin&rft.au=Sneve%2C+Markus&rft.date=2024&rft.pub=Elsevier+B.V&rft.issn=2666-2450&rft.eissn=2666-2450&rft.volume=6&rft_id=info:doi/10.1016%2Fj.cccb.2024.100308&rft.externalDocID=S2666245024001090 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2666-2450&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2666-2450&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2666-2450&client=summon |